Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
8 March 2012
Question for written answer
to the Commission
Rule 117
Karl-Heinz Florenz (PPE)

 Subject: Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products

The Cosmetics Regulation (Regulation (EC) No 1223/2009) provides for the prohibition of animal tests concerning repeated-dose toxicity, reproductive toxicity and toxicokinetics with effect from 11 March 2013.

The following questions arise if products or substances which have been tested using alternative methods only and have been placed on the market in the EU are subsequently tested outside the EU on animals:

1. In China, for instance, all cosmetic products and substances used in cosmetic products must be tested on animals before being placed on the Chinese market. Will substances which are tested on animals in China then have to be removed from the European market, or will an automatic exemption be granted from the ban in the event of subsequent testing on animals?
2. How does the Commission assess the problems that may arise in connection with hostile testing (conducting animal tests with the express intention of harming competitors) or, for example, scientific tests on animals, practices which foreign firms, say, could use to their advantage in order to force the products of their European competitors off the market when the ban comes into force in 2013?

Original language of question: DEOJ C 115 E, 23/04/2013
Last updated: 22 March 2012Legal notice